Henry Schein, Inc. (NASDAQ:HSIC) Shares Acquired by Mountain Pacific Investment Advisers Inc. ID

Mountain Pacific Investment Advisers Inc. ID lifted its position in shares of Henry Schein, Inc. (NASDAQ:HSIC) by 20.4% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 5,900 shares of the company’s stock after acquiring an additional 1,000 shares during the period. Mountain Pacific Investment Advisers Inc. ID’s holdings in Henry Schein were worth $447,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also made changes to their positions in the company. JPMorgan Chase & Co. raised its position in shares of Henry Schein by 1.1% during the 3rd quarter. JPMorgan Chase & Co. now owns 4,766,305 shares of the company’s stock valued at $353,898,000 after acquiring an additional 53,506 shares in the last quarter. American Century Companies Inc. raised its position in shares of Henry Schein by 7.3% during the 3rd quarter. American Century Companies Inc. now owns 4,719,088 shares of the company’s stock valued at $350,392,000 after acquiring an additional 322,649 shares in the last quarter. Northern Trust Corp raised its position in shares of Henry Schein by 2.8% during the 3rd quarter. Northern Trust Corp now owns 1,647,889 shares of the company’s stock valued at $122,356,000 after acquiring an additional 45,561 shares in the last quarter. Lazard Asset Management LLC raised its position in shares of Henry Schein by 1,303.3% during the 3rd quarter. Lazard Asset Management LLC now owns 1,247,334 shares of the company’s stock valued at $92,614,000 after acquiring an additional 1,158,451 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. raised its position in shares of Henry Schein by 1.0% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 1,107,940 shares of the company’s stock valued at $82,265,000 after acquiring an additional 11,490 shares in the last quarter. 96.62% of the stock is owned by institutional investors and hedge funds.

Henry Schein Trading Up 0.4 %

NASDAQ:HSIC opened at $73.13 on Friday. Henry Schein, Inc. has a 1 year low of $60.01 and a 1 year high of $82.63. The stock has a market cap of $9.40 billion, a price-to-earnings ratio of 23.22, a PEG ratio of 1.81 and a beta of 0.87. The business has a fifty day moving average of $74.17 and a 200-day moving average of $72.43. The company has a debt-to-equity ratio of 0.45, a quick ratio of 1.00 and a current ratio of 1.67.

Henry Schein (NASDAQ:HSIC) last released its quarterly earnings results on Tuesday, February 27th. The company reported $0.66 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.70 by ($0.04). Henry Schein had a return on equity of 14.03% and a net margin of 3.37%. The business had revenue of $3.02 billion during the quarter, compared to the consensus estimate of $3 billion. During the same period in the previous year, the company posted $1.21 EPS. The company’s revenue for the quarter was down 10.5% compared to the same quarter last year. Equities analysts predict that Henry Schein, Inc. will post 5.07 earnings per share for the current year.

Analysts Set New Price Targets

HSIC has been the subject of a number of recent research reports. Jefferies Financial Group upped their price objective on Henry Schein from $74.00 to $81.00 and gave the stock a “hold” rating in a research note on Wednesday, March 6th. Piper Sandler upped their price objective on Henry Schein from $78.00 to $86.00 and gave the stock an “overweight” rating in a research note on Monday, February 26th. Evercore ISI upped their price objective on Henry Schein from $79.00 to $83.00 and gave the stock an “in-line” rating in a research note on Wednesday, February 28th. TheStreet upgraded Henry Schein from a “c+” rating to a “b-” rating in a research note on Monday, February 26th. Finally, Leerink Partnrs restated a “market perform” rating on shares of Henry Schein in a research note on Monday, February 26th. One analyst has rated the stock with a sell rating, six have issued a hold rating and five have assigned a buy rating to the company’s stock. According to data from MarketBeat, Henry Schein currently has a consensus rating of “Hold” and a consensus target price of $81.09.

Insider Activity

In other news, Vice Chairman James P. Breslawski sold 2,907 shares of the company’s stock in a transaction on Monday, March 18th. The stock was sold at an average price of $74.37, for a total value of $216,193.59. Following the completion of the sale, the insider now owns 209,562 shares in the company, valued at $15,585,125.94. The sale was disclosed in a legal filing with the SEC, which is available at this link. In other news, CEO Bradford C. Connett sold 6,430 shares of the company’s stock in a transaction on Wednesday, March 20th. The stock was sold at an average price of $74.28, for a total value of $477,620.40. Following the completion of the sale, the chief executive officer now owns 73,108 shares in the company, valued at $5,430,462.24. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, Vice Chairman James P. Breslawski sold 2,907 shares of the company’s stock in a transaction on Monday, March 18th. The shares were sold at an average price of $74.37, for a total value of $216,193.59. Following the completion of the sale, the insider now owns 209,562 shares of the company’s stock, valued at approximately $15,585,125.94. The disclosure for this sale can be found here. Insiders own 1.14% of the company’s stock.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners and laboratories, physician practices, ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.